UNSPSC 51161711: Mepixanox

This classification denotes an anti-asthmatic agent with the molecular formula C20H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7419T4YQQW, chemically known as 9h-xanthen-9-one, 3-methoxy-4-(1-piperidinylmethyl)- but generally known as mepixanox, which bears US NIH Compound Identifier 65687. European Medicines Agency schedules Mepixanox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08754MIG.

UNSPSC 51161711 Mepixanox is a Commodity code that frames state and local procurement of pharmaceutical products and medical supplies related to naloxone and drug deactivation systems. Recent solicitations show state and local governments purchasing naloxone units and safe drug deactivation systems to support community health and emergency-response initiatives, alongside on-site pharmacy services that dispense controlled formularies to employee and retiree populations. Issuing bodies include county health departments and county government employee health programs. Seminole County, Florida, and Hall County, Georgia, both issued opportunities under or aligned with this code tier in the recent period.

Seminole County, Florida, posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. Hall County, Georgia, issued RFQ/P #47-010 on May 4, 2026, to procure on-site pharmacy services at the Hall County Government Family Health Center Clinic in Gainesville, serving approximately 3,005 eligible individuals across multiple insurance plan types, with sealed proposals due June 4, 2026, at 2:00 p.m. Eastern Time and a contract term beginning January 1, 2027. Both procurements require vendors to comply with E-Verify, provide proof of insurance, and meet federal compliance standards. The geographic spread captures activity in Florida and Georgia; the issuing-body mix reflects county health departments and employee benefits programs.